Skip to main content
. Author manuscript; available in PMC: 2019 Jul 15.
Published in final edited form as: Cancer Chemother Pharmacol. 2018 Dec 8;83(3):473–482. doi: 10.1007/s00280-018-3749-7

Table 2.

All adverse events by dose and grade*


Toxicity Category

Adverse Event
Dose Level 1
N=5
Dose Level 2
N=6
G1 G2 G1 G2
Blood and lymphatic Anemia 2 1 1 -
GI disorders Nausea - - 3 -
Injury/procedural Bruising - 1 - -
Hemorrhage 1 - - -
Investigations Creatinine increased - - 1 -
QTc prolonged 2 - 2 1
Platelets decreased - - 2 1
Metabolism Hyperglycemia 1 1 2 -
Hyperkalemia - - 1 -
Hypocalcemia 2 1 1 -
Nervous system Dizziness - - 1 -
Headache 3 - 1 1
Psychiatric Anxiety 1 - 1 -
*

There were no grade 3 or 4 drug related toxicities